Articles Vol. 66 No. CĐ1-NCKH 24/01/2025

49. THE PREVALENCE OF THYROID DISEASE IN PATIENTS WITH VITILIGO AT NATIONAL HOSPITAL OF DERMATOLOGY AND VENEREOLOGY

Pham Thi Phuong1,2, Vu Huy Luong3,4, Do Thi Thu Hien3,4
1 Hanoi Medical University
2 Trường Đại học Y Hà Nội
3 National Hospital of Dermatology and Venereology
4 Bệnh viện Da liễu Trung ương
Corresponding author: hienphuonglinh@yahoo.com
DOI: 10.52163/yhc.v66iCD1.2024
83 Views
85 Downloads
Keywords
Vitiligo thyroid disease autoimmune thyroid disease TRAb Anti-TPO
Abstract

Objectives: To determine the prevalence of thyroid disease in patients with vitiligo at National Hospital of Dermatology and Venereology.

Materials and methods: We performed cross-sectional study on 318 patients diagnosed with vitiligo at National Hospital of Dermatology and Venereology from November 2023 to June 2024. Serum samples from patients were collected and tested for TSH, FT3, FT4, TRAb, Anti-TPO. Ultrasound was used to evaluate thyroid morphology. The patients with abnormal test results were sent to endocrinologist to confirm the diagnosis of  thyroid disease.

Results: Of the 318 patients, 36 (11.3%) patients had thyroid dysfunction including  hyperthyroidism (3.4%) and hypothyroidism (7.9%). The prevalence of thyroid disease was 22%, of which autoimmune thyroid disease accounted for 8.2%, thyroid nodule accounted for 12.9% and thyroid cancer accounted for 0.9%. TRAb and Anti-TPO positivity rates were 3.1% and 17.3%.

Conclusion: The study results suggested that screening for thyroid disease should be recommended in patients with vitiligo.

References
[1]
Taïeb A, Picardo M, Clinical practice, Vitiligo, N Engl J Med, 2009, 360 (2): 160-169, doi:10.1056/NEJMcp0804388. Google Scholar
[2]
Krüger C, Schallreuter K.U, A review of the worldwide prevalence of vitiligo in children/adolescents and adults, Int J Dermatol, 2012, 51 (10): 1206-1212, doi:10.1111/j.1365-4632.2011.05377.x. Google Scholar
[3]
Ezzedine K, Lim H.W, Suzuki T et al, Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, Pigment Cell Melanoma Res, 2012, 25 (3): E1-13, doi:10.1111/j.1755-148X.2012.00997.x. Google Scholar
[4]
Picardo M, Dell’Anna M.L, Ezzedine K et al, Vitiligo, Nat Rev Dis Primers, 2015, 1: 15011, doi:10.1038/nrdp.2015.11. Google Scholar
[5]
Vrijman C, Kroon M.W, Limpens J et al, The prevalence of thyroid disease in patients with vitiligo: a systematic review, Br J Dermatol, 2012, 167 (6): 1224-1235, doi:10.1111/j.1365-2133.2012.11198.x. Google Scholar
[6]
Baldini E, Odorisio T, Sorrenti S et al, Vitiligo and Autoimmune Thyroid Disorders, Frontiers in Endocrinology, 2017, 8, doi:10.3389/fendo.2017.00290. Google Scholar
[7]
Bae J.M, Lee J.H, Yun J.S, Han B, Han T.Y, Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea, J Am Acad Dermatol, 2017, 76 (5): 871-878, doi:10.1016/j.jaad.2016.12.034. Google Scholar
[8]
Fan K.C, Yang T.H, Huang Y.C, Vitiligo and thyroid disease: a systematic review and meta-analysis, Eur J Dermatol, 2018, 28 (6): 750-763, doi:10.1684/ejd.2018.3449. Google Scholar
[9]
Nguyễn Thái Minh Hảo, Đỗ Thị Thu Hiền, Hiệu quả điều trị bạch biến thể khu trú bằng bôi tacrolimus kết hợp chiếu đèn excimer, TC DLH VN, 2022, (35): 37-44, doi:10.56320/tcdlhvn.v35i.3. Google Scholar
[10]
Đỗ Thị Hồng Nhung, Đỗ Thị Thu Hiền, Trần Hậu Khang, Hiệu quả điều trị bệnh bạch biến bằng chiếu UVB dải hẹp 311nm, Tạp chí Y học Việt Nam, 2017, 461 (1): 100-104. Google Scholar
[11]
Nguyễn Thị Thanh Huyền, Nguyễn Trọng Hào, Bệnh tuyến giáp tự miễn và các yếu tố liên quan trên bệnh nhân bạch biến tại Bệnh viện Da liễu thành phố Hồ Chí Minh, TC DLH VN, 2022, (35): 28-36, doi:10.56320/tcdlhvn.v35i.2. Google Scholar
[12]
Chauhan P.S, Sharma H, Dhattarwal N et al, Characteristics of Vitiligo in Children and Adolescents, Skinmed, 2020, 18 (5): 278-285. Google Scholar
[13]
Gopal K.V.T, Rao G.R, Kumar Y.H, Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study, Indian Dermatol Online J, 2014, 5 (4): 456-460, doi:10.4103/2229-5178.142493. Google Scholar
[14]
Kroon M.W, Joore I.C.K.W, Wind B.S et al, Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo, Br J Dermatol, 2012, 166 (3): 532-538, doi:10.1111/j.1365-2133.2011.10717.x. Google Scholar
[15]
Yang Y, Lin X, Fu W, Luo X, Kang K, An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children, Clin Exp Dermatol, 2010, 35 (7): 706-710,doi:10.1111/j.1365-2230.2009.03671.x. Google Scholar
[16]
Trần Viết Thắng, Tiếp cận chẩn đoán và điều trị bướu giáp nhân, Thời sự y học, Published online, 2014, 19-22. Google Scholar
[17]
Antonelli A, Ferrari S.M, Corrado A, Di Domenicantonio A, Fallahi P, Autoimmune thyroid disorders, Autoimmun Rev, 2015, 14 (2): 174-180, doi:10.1016/j.autrev.2014.10.016. Google Scholar